Holdings of Invesco Pharmaceuticals ETF
Invesco Exchange-Traded Fund Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 472.1M $ including 471.7M $ in equities, 99.9 %
- Positions
- 28 in 2 countries
- Top ten
- 49.5 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 253,317 | 26.8M $ | 5.67 % |
| 2 | AbbVie Inc | 103,038 | 25.9M $ | 5.48 % |
| 3 | Amgen Inc | 65,359 | 25.2M $ | 5.33 % |
| 4 | Johnson & Johnson | 95,373 | 24.4M $ | 5.18 % |
| 5 | Merck & Co Inc | 183,363 | 23.9M $ | 5.06 % |
| 6 | Eli Lilly & Co | 20,622 | 23.7M $ | 5.02 % |
| 7 | Corcept Therapeutics Inc | 204,618 | 23.4M $ | 4.96 % |
| 8 | Gilead Sciences Inc | 164,182 | 21.4M $ | 4.53 % |
| 9 | Pfizer Inc | 849,353 | 21.2M $ | 4.50 % |
| 10 | Amneal Pharmaceuticals Inc | 965,545 | 17.7M $ | 3.75 % |
| 11 | Liquidia Corp | 205,492 | 17.3M $ | 3.66 % |
| 12 | TRAVERE THERAPEUTICS INC | 278,876 | 15.6M $ | 3.30 % |
| 13 | Ligand Pharmaceuticals Inc | 52,490 | 15.1M $ | 3.20 % |
| 14 | Regeneron Pharmaceuticals Inc | 19,460 | 14.8M $ | 3.14 % |
| 15 | Harmony Biosciences Holdings Inc | 410,448 | 14.5M $ | 3.06 % |
| 16 | Bristol-Myers Squibb Co | 212,823 | 13.9M $ | 2.94 % |
| 17 | VIATRIS INC | 759,533 | 13.3M $ | 2.83 % |
| 18 | JAZZ PHARMACEUTICALS PLC | 52,047 | 13.2M $ | 2.79 % |
| 19 | Biogen Inc | 63,929 | 13M $ | 2.75 % |
| 20 | Collegium Pharmaceutical Inc | 365,632 | 12.9M $ | 2.74 % |
| 21 | Prestige Consumer Healthcare Inc | 257,185 | 12.9M $ | 2.74 % |
| 22 | OCULAR THERAPEUTIX INC | 1,489,689 | 12.2M $ | 2.58 % |
| 23 | ANI Pharmaceuticals Inc | 151,712 | 12M $ | 2.55 % |
| 24 | TARSUS PHARMACEUTICALS INC | 201,930 | 11.9M $ | 2.53 % |
| 25 | Perrigo Co PLC | 1,143,527 | 11.6M $ | 2.45 % |
| 26 | Supernus Pharmaceuticals Inc | 258,498 | 11.5M $ | 2.44 % |
| 27 | Innoviva Inc | 544,496 | 11.4M $ | 2.42 % |
| 28 | United Therapeutics Corp | 21,361 | 11.1M $ | 2.34 % |
Sector breakdown
- Health care 54.8 %
- Unattributed 45.2 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.8 %
- Ireland 5.2 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 26 | 447M $ | 94.76 % |
| 2 | Ireland | 2 | 24.7M $ | 5.24 % |
Cite this page
Titelia. "Holdings of Invesco Pharmaceuticals ETF". https://titelia.com/en/funds/S000003031